 |
The inherent disconnect between visionaries and real-world implementation may be universal, but it sure seems to pervade life sciences these days. As biopharma companies enter a new epoch of decentralized clinical trials, precision medicine and translational research, many encounter challenges when connecting operations with the master vision. C-suite members understandably want to capitalize on the wave of tech innovation and data science in R&D. But this must be balanced with day-to-day operational concerns such as resource allocation, change management and regulatory matters that impact overall practicality. Inside this playbook, we talk with experts to understand:
|
